Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medical implant component comprising composite biotextile and method of making

A technology of implants and textiles, applied in the field of manufacturing such components and medical implants, can solve the problems of insufficient bonding strength of stable materials, increase the embolism and reduction of foreign particles, and achieve the improvement of interaction or biocompatibility. Effect

Active Publication Date: 2021-10-19
DSM IP ASSETS BV
View PDF29 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Specifically, disadvantages of typical stabilization techniques can include (i) the additional profile of components and devices, requiring larger catheters to implant them, (ii) potentially less than optimal blood contact properties such as thrombogenicity Additional material, (iii) deformation of the biotextile at the cutting edge, (iv) insufficient bonding strength of the stabilizing material to increase the risk of embolization of foreign particles in the bloodstream, and (v) stiffening or reduced flexibility of the biotextile

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medical implant component comprising composite biotextile and method of making
  • Medical implant component comprising composite biotextile and method of making
  • Medical implant component comprising composite biotextile and method of making

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0193] Examples and Comparative Examples

[0194] Material

[0195] The polyolefin textile used as starting material in the examples is made from medical grade low denier UHMWPE multifilament yarn (Dyneema TG 10 dtex; commercially available from DSM Biomedical BV, Sittard-Geleen NL) as warp and weft strands made into a woven fabric with a planar width of 45 mm and a thickness of about 70 μm with a 2*2 twill weave pattern.

[0196] As polyurethane elastomer the following grades were used (commercially available from DSM Biomedical BV, Sittard-Geleen NL):

[0197] - TSPCU 20-80A; thermoplastic silicone polycarbonate polyurethane (thermoplasticsilicone polycarbonate polyurethane), containing silicone in the soft segment and having silicone end groups and having silicone end groups, with a hardness of 80 ShA and an MFR of 52 g / 10 minutes (1.20kg / 224℃);

[0198] - S SPU, polyether urethane containing urea groups and segments with silicone end groups, hardness about 74 ShA. ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
thicknessaaaaaaaaaa
molecular weightaaaaaaaaaa
tenacityaaaaaaaaaa
Login to View More

Abstract

Disclosed herein is a medical implant component comprising a composite biotextile, which biotextile comprises i) a polyolefin fibrous construct comprising at least one strand with titer of 2-250 dtex, tensile strength of at least 10 cN / dtex and comprising high molar mass polyolefin fibers; and ii) a coating comprising a biocompatible and biostable polyurethane elastomer comprising polysiloxane in soft segments and / or having one or more hydrophobic endgroups, wherein the polyurethane coating has been applied to at least part of the surface of the biotextile and in an amount of 2.5-90 mass% based on composite biotextile. At least one strand of such composite biotextile, for example a partly coated woven fabric, shows an advantageous combination of good biocompatibility, especially hemocompatibility, high strength and pliability, and laser cuttability; allowing to make pieces of fabric having well-defined regular edges that have high suture retention strength. The invention also provides a method of making the composite biotextile. Further embodiments concern the use of such biotextile in a medical implant component for an implantable medical device and the use of such medical implant component in making an implantable medical device; such as in orthopedic applications and cardiovascular implants. Other embodiments include such medical devices or implants comprising the medical implant component.

Description

technical field [0001] The disclosed invention relates to biotextiles, and more particularly, to medical implant components based on modified polyolefin fiber constructs, to methods of making such components, and to the use of such components in the manufacture of medical implants . Background technique [0002] The term medical textile is generally used for flexible materials made of fibrous networks that are used outside the body and are not in contact with circulating blood or open wounds, such as bandages, dressings, eye masks, incontinence products, braces, surgical Use curtains, masks, etc. Biotextiles refer to non-viable, permanent or temporary fibrous structures such as cables and textiles made of synthetic or natural fibers, which are used in internal (inside the body) or external (outside the body) biological environments as The use of medical devices to prevent, treat or diagnose injury or disease, and thereby improve the health, medical condition, comfort and w...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61L27/16A61L27/34C08L23/06C08L75/04
CPCA61L27/16A61L27/34C09D175/04C08G18/837C08G18/61C08G18/48C08G18/4009C08G18/3206C08G18/3225C08G18/2815C08G18/283C08G18/2885C08G18/289C08G18/7621C08G18/7671C08G18/7614A61L27/56D06N2211/18A61L2430/02A61L31/048D06N3/0006A61L31/146C08G18/44D06N3/14D06M15/564A61L2430/20A61L31/10D06N3/0038
Inventor 尼古拉斯·胡伯图斯·玛丽亚·德邦特诺埃尔·L·戴维森曼迪·玛丽亚·乔泽菲娜·维尔曼
Owner DSM IP ASSETS BV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products